Novartis Aktie
99,06
EUR
+1,22
EUR
+1,25
%
92,15
CHF
+0,60
CHF
+0,66
%
Werbung
Novartis Aktie Analyse
03.06.05 | Novartis | Der Aktionärsbrief | |
02.06.05 | Novartis neutral | Bank Sarasin & Cie | |
02.06.05 | Novartis above average | Caris & Company | |
01.06.05 | Novartis Above Average | Caris & Company | |
27.05.05 | Novartis buy | Jyske Bank | |
20.05.05 | Novartis | JRC | |
20.05.05 | Novartis | JRC | |
10.05.05 | Novartis Buy | Smith Barney Citigroup | |
Werbung
|
|||
27.04.05 | Novartis Sector Perform | Vontobel | |
25.04.05 | Novartis Kaufen | Hamburger Sparkasse | |
22.04.05 | Novartis Hold | SEB | |
22.04.05 | Novartis Outperform | Goldman Sachs | |
22.04.05 | Novartis Overweight | Lehman Brothers | |
22.04.05 | Novartis Kaufen | NATIONAL-BANK | |
21.04.05 | Novartis Akkumulieren | Independent Research | |
21.04.05 | Novartis Neutral | Sarasin Research | |
21.04.05 | Novartis Buy | Merrill Lynch | |
21.04.05 | Novartis Kaufen | Helaba Trust | |
19.04.05 | Novartis Underperform | Credit Suisse First Boston | |
19.04.05 | Novartis Buy | Merrill Lynch | |
18.04.05 | Novartis Neutral | JP Morgan | |
18.04.05 | Novartis Outperform | Goldman Sachs | |
15.04.05 | Novartis Neutral | HypoVereinsbank | |
15.04.05 | Novartis Kaufen | Helaba Trust | |
15.04.05 | Novartis Neutral | Sarasin Research | |
14.04.05 | Novartis Reduce | UBS | |
14.04.05 | Novartis Reduce | UBS | |
14.04.05 | Novartis Underperform | Credit Suisse First Boston | |
13.04.05 | Novartis Neutral | Sarasin Research | |
08.04.05 | Novartis Accumulate | Helvea | |
21.03.05 | Novartis Accumulate | Helvea | |
21.03.05 | Novartis Neutral | Sarasin Research | |
21.03.05 | Novartis Kaufen | Helaba Trust | |
18.03.05 | Novartis Neutral | Sarasin Research | |
16.03.05 | Novartis Outperform | Goldman Sachs | |
11.03.05 | Novartis Buy | Helvea | |
11.03.05 | Novartis Neutral | Sarasin Research | |
10.03.05 | Novartis Neutral | Sarasin Research | |
09.03.05 | Novartis Buy | Merrill Lynch | |
07.03.05 | Novartis Neutral | Sarasin Research | |
24.02.05 | Novartis Overweight | Lehman Brothers | |
22.02.05 | Novartis Buy | Helvea | |
22.02.05 | Novartis Outperform | Goldman Sachs | |
21.02.05 | Novartis Kaufen | Helaba Trust | |
21.02.05 | Novartis Hold | SEB | |
21.02.05 | Novartis Neutral | Sarasin Research | |
21.02.05 | Novartis Buy | Helvea | |
21.02.05 | Novartis Akkumulieren | Independent Research | |
09.02.05 | Novartis Buy | Merrill Lynch | |
02.02.05 | Novartis Übergewichten | Reuschel & Co |
Werbung
Werbung